The Taiwan Food and Drug Administration (TFDA) denied EUA for UB-612 in August, citing that the vaccine failed to meet the two efficacy standards for granting EUA in its experts review
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3wrHju1
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Aurobindo Pharma's COVID-19 vaccine plan in limbo after partner fails to get EUA in Taiwan
https://ift.tt/eA8V8J
No comments:
Post a Comment